x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

I took four COVID-19 tests; two were positive, two negative — Tesla CEO Musk

Health & Science - By Reuters | November 13th 2020 at 09:44:23 GMT +0300
Tesla CEO Elon Musk [Reuters]

Tesla Inc TSLA.O Chief Executive Officer Elon Musk said on Thursday he took four coronavirus tests on the same day, with two showing positive results, while the other two were negative.

"Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD," Musk said in a tweet, possibly referring to Becton Dickinson and Co's BDX.N rapid antigen test.

The Tesla CEO said he was also undergoing polymerase chain reaction (PCR) tests from separate labs whose results will take about 24 hours.

When asked by a Twitter user if he showed any symptoms, Musk said he had symptoms of a “typical cold”.

“Nothing unusual so far,” Musk added.

Covid 19 Time Series

 

Becton Dickinson said in September it was investigating reports from U.S. nursing homes that its rapid coronavirus testing equipment was producing false-positive results.

Becton Dickinson did not respond to a request for comment late on Thursday.

Covid-19 vaccine

Pfizer on Monday said its experimental vaccine was more than 90 per cent effective in preventing Covid-19 based on initial data from a large study, a major victory in the fight against a pandemic that has killed over 1 million people, roiled the world’s economy and upended daily life.

Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns and expect to seek US emergency use authorisation later this month.

If authorised, the number of vaccine doses will initially be limited. Many questions also remain including how long the vaccine will provide protection. However, the news provides hope that other vaccines in development against the novel coronavirus may also prove effective.

“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chairman and chief executive, said in a statement. “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”

Pfizer expects to seek broad US emergency use authorisation of the vaccine for people aged 16 to 85. To do so, it will need to have collected two months of safety data on around half of the study’s roughly 44,000 participants, expected in late November.

Top Stories

Hospital swamped as patient numbers swell
Health & Science - By Mercy Kahenda


139 test Covid-19 positive as cases near 100,000
Health & Science - By Betty Njeru


NMS recruits 600 nurses as it prepares to open four hospitals
Health & Science - By Josephat Thiong'o


Africa's COVID-19 case fatality rate surpasses global level
Health & Science - By Reuters


A virus that reverses deafness
Health & Science - By Killiad Sinide


Covid-19 cases to shoot up in March
Health & Science - By Mercy Kahenda


Concern over soaring cases of liver failure and liver cancer among Kenyans due to Hepatitis
Health & Science - By Ally Jamah


Government now approves Janssen’s Prostate Cancer drug
Health & Science - By Mireri Junior


Concern over soaring cases of liver failure and liver cancer among Kenyans due to Hepatitis
Health & Science - By Ally Jamah


Why matumbo is good for fertility, pregnancy
Health & Science - By Dr Othieno Joseph


Latest Stories

Hospital swamped as patient numbers swell
Health & Science - By Mercy Kahenda


Covid-19 cases to shoot up in March
Health & Science - By Mercy Kahenda


NMS recruits 600 nurses as it prepares to open four hospitals
Health & Science - By Josephat Thiong'o


139 test Covid-19 positive as cases near 100,000
Health & Science - By Betty Njeru


Covid-19: Three dead as 186 test positive
Health & Science - By Judah Ben-Hur


Africa's COVID-19 case fatality rate surpasses global level
Health & Science - By Reuters


We'll go on with strike, healthcare workers say
Health & Science - By Anyango Otieno and Kirsten Kanja


COVID-19 shots to cost between Sh300 and Sh1100 under African Union vaccine plan
Health & Science - By Reuters


Covid-19: Kenya records 136 new cases as 176 recover
Health & Science - By Judah Ben-Hur


Muslim Council calls on governors to heal health crisis
Health & Science - By Judah Ben-Hur


//

Stay Ahead!

Access premium content only available
to our subscribers.

Or Login With Your Standard Account
Support independent journalism
×
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in